[Form 4] Axon Enterprise, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Joshua Isner, an officer (President) of Axon Enterprise, reported multiple sales of the company’s common stock executed on 08/07/2025. The Form 4 lists five sale tranches that together total 2,500 shares sold, with reported weighted-average sale prices of $867.4875, $868.50, $869.7092, $871.2756 and $872.1513, and disclosed execution price ranges approximately $867.15 to $872.34.

After these transactions the reporting person is shown as directly owning 266,235 shares. No derivative securities were reported and the filer offers to provide full trade-level details to the SEC or security holders upon request.

Insights

Financial Analyst

TL;DR: Officer sold 2,500 Axon shares across five tranches at weighted-average prices near $867–$872; ownership remains substantial at 266,235 shares.

The filing documents routine insider disposition activity rather than option exercises or derivative actions. The sales are disclosed as five separate tranches on a single date with explicit weighted-average prices and execution ranges, which improves transparency for investors. Given the relatively small size of the sale versus the remaining direct holding, this disclosure is unlikely to materially affect valuation models by itself, but it updates the public record of insider liquidity.

Corporate Governance Expert

TL;DR: Transparent Form 4 disclosure of multiple sales by the President; no derivatives reported and the filer offers to provide trade details on request.

The form complies with Section 16 reporting requirements, showing clear transaction codes and weighted-average prices per tranche. The reporting person maintained direct ownership of 266,235 shares after the sales, and the explanatory footnotes document execution price ranges and willingness to produce granular trade information. From a governance perspective the filing meets disclosure standards and does not indicate any procedural irregularity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Isner Joshua

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2025		S		200	D	$867.4875(1)	268,535	D
Common Stock	08/07/2025		S		159	D	$868.5	268,376	D
Common Stock	08/07/2025		S		448	D	$869.7092(2)	267,928	D
Common Stock	08/07/2025		S		712	D	$871.2756(3)	267,216	D
Common Stock	08/07/2025		S		981	D	$872.1513(4)	266,235	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was executed in multiple trades at prices ranging from $867.15 to $867.825. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. The transaction was executed in multiple trades at prices ranging from $869.56 to $870.13. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. The transaction was executed in multiple trades at prices ranging from $870.61 to $871.585. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. The transaction was executed in multiple trades at prices ranging from $871.6579 to $872.34. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Joshua Isner, by Isaiah Fields, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for AXON report?

The Form 4 reports that officer Joshua Isner executed multiple sales of Axon common stock on 08/07/2025, totaling 2,500 shares.

How many AXON shares were sold and in how many tranches?

A total of 2,500 shares were sold across five separate tranches on the reported date.

At what prices were the AXON shares sold?

Weighted-average sale prices reported for the tranches were $867.4875, $868.50, $869.7092, $871.2756, and $872.1513, with execution ranges approximately $867.15 to $872.34.

How many AXON shares does the reporting person own after the transactions?

The Form 4 shows the reporting person directly owning 266,235 shares following the reported transactions.

Were any derivative securities reported on the Form 4 for AXON?

No. Table II lists no derivative securities; only common stock dispositions are reported in Table I.